Assessment and treatment of depression in the cancer patient

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

The prevalence, diagnosis, and treatment of depression in the cancer patient are reviewed. Although frequently encountered in the cancer patient population, depression often remains undiagnosed and untreated. This carries grave consequences in that depressed cancer patients experience a poorer quality of life, are less compliant with medical care, have longer hospital stays, and have higher mortality rates. Diagnostic assessment of depression in the cancer patient raises difficulties both upon phenomenological and etiological grounds. In particular, the presence of neurovegetative symptoms which may be secondary to either cancer or depression may cloud the diagnostic picture. Due to the serious consequences of unrecognized depression, a more sensitive inclusive approach to diagnosis is recommended in the clinical setting. Finally, the limited data regarding treatment of depression in patients with cancer is reviewed. This includes a discussion of both psychosocial and pharmacological interventions which are shown to alleviate depression, improve quality of life measures, improve immune function, and lengthen survival time.

Original languageEnglish
Pages (from-to)215-237
Number of pages23
JournalJournal of Psychosomatic Research
Volume45
Issue number3
DOIs
StatePublished - Sep 1 1998
Externally publishedYes

Fingerprint

Neoplasms
Therapeutics
Quality of Life
Length of Stay
Pharmacology
Survival
Mortality
Population

Keywords

  • Cancer
  • Depression
  • Psycho-oncology

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Psychology(all)

Cite this

Assessment and treatment of depression in the cancer patient. / Newport, Donald J; Nemeroff, Charles.

In: Journal of Psychosomatic Research, Vol. 45, No. 3, 01.09.1998, p. 215-237.

Research output: Contribution to journalArticle

@article{e7a0e635cdd44193b1d819a6fa5114eb,
title = "Assessment and treatment of depression in the cancer patient",
abstract = "The prevalence, diagnosis, and treatment of depression in the cancer patient are reviewed. Although frequently encountered in the cancer patient population, depression often remains undiagnosed and untreated. This carries grave consequences in that depressed cancer patients experience a poorer quality of life, are less compliant with medical care, have longer hospital stays, and have higher mortality rates. Diagnostic assessment of depression in the cancer patient raises difficulties both upon phenomenological and etiological grounds. In particular, the presence of neurovegetative symptoms which may be secondary to either cancer or depression may cloud the diagnostic picture. Due to the serious consequences of unrecognized depression, a more sensitive inclusive approach to diagnosis is recommended in the clinical setting. Finally, the limited data regarding treatment of depression in patients with cancer is reviewed. This includes a discussion of both psychosocial and pharmacological interventions which are shown to alleviate depression, improve quality of life measures, improve immune function, and lengthen survival time.",
keywords = "Cancer, Depression, Psycho-oncology",
author = "Newport, {Donald J} and Charles Nemeroff",
year = "1998",
month = "9",
day = "1",
doi = "10.1016/S0022-3999(98)00011-7",
language = "English",
volume = "45",
pages = "215--237",
journal = "Journal of Psychosomatic Research",
issn = "0022-3999",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Assessment and treatment of depression in the cancer patient

AU - Newport, Donald J

AU - Nemeroff, Charles

PY - 1998/9/1

Y1 - 1998/9/1

N2 - The prevalence, diagnosis, and treatment of depression in the cancer patient are reviewed. Although frequently encountered in the cancer patient population, depression often remains undiagnosed and untreated. This carries grave consequences in that depressed cancer patients experience a poorer quality of life, are less compliant with medical care, have longer hospital stays, and have higher mortality rates. Diagnostic assessment of depression in the cancer patient raises difficulties both upon phenomenological and etiological grounds. In particular, the presence of neurovegetative symptoms which may be secondary to either cancer or depression may cloud the diagnostic picture. Due to the serious consequences of unrecognized depression, a more sensitive inclusive approach to diagnosis is recommended in the clinical setting. Finally, the limited data regarding treatment of depression in patients with cancer is reviewed. This includes a discussion of both psychosocial and pharmacological interventions which are shown to alleviate depression, improve quality of life measures, improve immune function, and lengthen survival time.

AB - The prevalence, diagnosis, and treatment of depression in the cancer patient are reviewed. Although frequently encountered in the cancer patient population, depression often remains undiagnosed and untreated. This carries grave consequences in that depressed cancer patients experience a poorer quality of life, are less compliant with medical care, have longer hospital stays, and have higher mortality rates. Diagnostic assessment of depression in the cancer patient raises difficulties both upon phenomenological and etiological grounds. In particular, the presence of neurovegetative symptoms which may be secondary to either cancer or depression may cloud the diagnostic picture. Due to the serious consequences of unrecognized depression, a more sensitive inclusive approach to diagnosis is recommended in the clinical setting. Finally, the limited data regarding treatment of depression in patients with cancer is reviewed. This includes a discussion of both psychosocial and pharmacological interventions which are shown to alleviate depression, improve quality of life measures, improve immune function, and lengthen survival time.

KW - Cancer

KW - Depression

KW - Psycho-oncology

UR - http://www.scopus.com/inward/record.url?scp=0032170520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032170520&partnerID=8YFLogxK

U2 - 10.1016/S0022-3999(98)00011-7

DO - 10.1016/S0022-3999(98)00011-7

M3 - Article

VL - 45

SP - 215

EP - 237

JO - Journal of Psychosomatic Research

JF - Journal of Psychosomatic Research

SN - 0022-3999

IS - 3

ER -